Ryu Tiger YK, Jain S, Barta SK, Tolu S, et al. Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma. Leuk Lymphoma 2024 Mar 22:1-10. doi: 10.1080/10428194.2024.2329996.
PMID: 38517235